#USA #St. Petersburg #Clinical Research #H Clinical #Emerald Square Ventures

H Clinical Secures Major Investment from Emerald Square Ventures

H Clinical, a prominent player in the realm of clinical research in Latin America, revealed an exciting new chapter in its journey with the announcement of a majority investment from Emerald Square Ventures (ESV) on September 16, 2026. This strategic partnership is expected to significantly bolster H Clinical's capacity in various aspects of clinical trials, enhancing its service offerings that cater to sponsors and contract research organizations (CROs) across the region.

The Vision Behind the Investment

Mitchell Parrish, the CEO of H Clinical, expressed his enthusiasm about the partnership, stating, "What we have spent six years building is difficult to construct and impossible to shortcut — people in the communities where trials run, their relationships with sites, and the infrastructure behind them." His statement highlights the company’s commitment to maintaining a strong local presence, which is integral to successful patient recruitment and trial management.

The majority investment from ESV is set to enable H Clinical to expand its staffing capabilities, enhance patient recruitment strategies, and improve the delivery of hybrid clinical trials — a format that combines in-person and remote interactions to optimize patient engagement.

Expansion of Leadership Team

In conjunction with the investment, H Clinical has made strategic additions to its executive team. Ben Joers joins as Chief Financial Officer, where he will oversee financial strategies and planning, ensuring sustainable growth for the company. Additionally, Eddie Hannush has been appointed as Chief Commercial Officer, charting a path for commercial strategy and fostering client relationships. Hannush remarked on the efficiency of integrated services, saying, "When staffing, recruitment, home visits, and logistics operate from a unified local platform, studies progress more quickly, and patients enjoy a streamlined experience."

Service Offerings on the Rise

With the investment from ESV, H Clinical plans to broaden its service offerings that are demanded by clients, which include:

• - Site Solutions and Project Staffing: H Clinical will source, train, and manage clinical research coordinators, nurses, and other essential personnel for sites across the region.
• - Community-Based Patient Recruitment: The company will enhance efforts through patient engagement teams that collaborate with referring physicians, health centers, and local organizations.
• - In-Home and Hybrid Trial Support: Patients can expect study visits in their own homes, complete with sample collection and comprehensive support for regulatory needs.
• - Procurement and Logistics: To facilitate seamless operations, H Clinical will establish regional depots and strengthen its local sourcing to optimize equipment rental and courier services.

A Leader in Latin American Clinical Research

H Clinical has claimed its position as the leading clinical research operating platform throughout 22 countries in Latin America. The company has enhanced its presence and efficacy in the field by collaborating with sponsors, CROs, and research sites, applying an adaptable approach to trial needs. With the largest in-home trial support network in the region, H Clinical ensures that sponsors can reach underrepresented patient populations effectively.

Looking Ahead

The investment from Emerald Square Ventures marks a pivotal moment for H Clinical as it prepares to navigate the complexities of clinical research. By leveraging local teams and fostering strong community ties, H Clinical aims to support its clients more robustly and ensure efficient trial delivery. Stakeholders interested in partnership or trial support opportunities are encouraged to reach out as H Clinical looks to further invest in its capabilities and expand its impact in the clinical research arena.

About H Clinical

H Clinical is known for its innovative approach to clinical research operations in Latin America, providing essential support to sponsors and contract research organizations. The company's commitment to community engagement and quality service has positioned it as a go-to partner for clinical trial logistics and patient support.

About Emerald Square Ventures

Emerald Square Ventures focuses on acquiring and growing businesses within the clinical research and life sciences sectors, further enhancing operational efficiencies and market reach.